Click on a filter below to refine your search. Remove a filter to broaden your search.
The hazard ratio for all-cause mortality was 2.69 for those with a diagnosis at 30 to 39 years and 1.39 for those with a diagnosis at 70 years or older.
All participants exceeded twofold increase in spike-specific IgG, with a geometric mean fold risk of 19.5 on day 57.
Solriamfetol was found to be well-tolerated with no significant effect on mean heart rate or systolic or diastolic blood pressure.
Age-standardized prevalence rates were higher among women than men, veterans than nonveterans and non-Hispanic whites.
A decreased use of insulin and sulfonylureas was seen postintervention.
Burnout was the highest in women, primary care physicians and physicians with ≤10 years of experience.
Estimated mean change from baseline in HbA1c was −2.1% with tirzepatide, which met noninferiority criteria and achieved superiority.
The benefits include both blood sugar control and weight loss.
Chatbot-generated answers had high accuracy and completeness scores for physician-developed medical queries.
The updated shot is expected to better target variants that are circulating now and help prevent hospitalization and death from the virus.